Dynamic WT1 expression during gastrulation specifies peritoneal smooth muscle fate independently of mesothelial fate
Development · 2025
DOI: 10.1242/dev.204332 ↗Kurz gefasst
Fachartikel in der Zeitschrift Development, 2025. Verfasst von Suad H Alsukari und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Women's and Children's Health, Institute of Life Course and Medical Sciences, Faculty of Health and Life Sciences, University of Liverp…. Hauptthemen laut MEDLINE: WT1 Proteins, Gastrulation, Peritoneum, Muscle, Smooth. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MRC Medical Research Council, BBSRC Doctoral Training Partnership scheme, BBSRC.
Abstract (Originalsprache)
The Wilms' tumor protein (WT1) was previously linked to the mesothelial and vascular smooth muscle cell (vSMC) lineage in the mouse intestine, with evidence suggesting that intestinal vSMCs arise from the mesothelium. Here, we report that WT1 is already expressed, unexpectedly, during mouse gastrulation, in cells that specify a population of SMC precursor cells in the lateral plate mesoderm. Tamoxifen-induced genetic lineage tracing of Wt1-expressing cells revealed that vSMC and visceral smooth muscle cells (visSMCs) of the foetal mid-gut, but not mesothelial cells, were labelled after tamoxifen administration at embryonic day (E) 7.5 or E8.5. Analysis of single-cell RNA sequencing datasets of gastrulation-stage mouse embryos and confocal microscopy demonstrated Wt1 expression in epiblast, primitive streak, emerging mesoderm and, from E7.5 onwards, in the lateral plate mesoderm. Co-expression of signature smooth muscle markers in Wt1-expressing cells in gastrulation-stage embryos revealed that vSMC and visSMC fate is specified independently of visceral mesothelium formation. Furthermore, tamoxifen-induced Wt1 knock out at E7.5 affected vascularisation in the E12.5 intestine. Taken together, our study provides previously unknown insights into the developmental lineage of smooth muscle specified by WT1 expression during gastrulation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Women's and Children's Health, Institute of Life Course and Medical Sciences, Faculty of Health and Life Sciences, University of Liverpool, Liverpool L69 3BX, UK.
- Department of Musculoskeletal and Ageing Science, Institute of Life Course and Medical Sciences, Faculty of Health and Life Sciences, University of Liverpool, Liverpool L7 8TX, UK.
ORCID-Profile: Huei Teng Ng, Sharna Lunn, David A Turner, Bettina Wilm
Förderung
- MRC Medical Research Council
- BBSRC Doctoral Training Partnership scheme
- BBSRC
- David Sainsbury NC3Rs Fellowship
- Medical Research Council
- Biotechnology and Biological Sciences Research Council
- Albaha University
- National Centre for the Replacement, Refinement and Reduction of Animals in Research
Zitieren
APA
Alsukari, S. H., Ng, H. T., Lang, L., Lunn, S., Beglinger, S., Carr, L., Boyes, M., Turner, D. A., & Wilm, B. (2025). Dynamic WT1 expression during gastrulation specifies peritoneal smooth muscle fate independently of mesothelial fate. Development. https://doi.org/10.1242/dev.204332
Vancouver
Alsukari SH, Ng HT, Lang L, Lunn S, Beglinger S, Carr L, et al. Dynamic WT1 expression during gastrulation specifies peritoneal smooth muscle fate independently of mesothelial fate. Development. 2025. doi:10.1242/dev.204332
BibTeX
@article{Alsukari2025,
author = {Alsukari, Suad H and Ng, Huei Teng and Lang, Lilly and Lunn, Sharna and Beglinger, Shanthi and Carr, Lauren and Boyes, Michael and Turner, David A and Wilm, Bettina},
title = {Dynamic WT1 expression during gastrulation specifies peritoneal smooth muscle fate independently of mesothelial fate},
journal = {Development},
year = {2025},
doi = {10.1242/dev.204332}
}
EUVIMED